Research and Markets: Cardiovascular Surgery Devices Market to 2017 - Technological Advances and Shift Towards Minimally Invasive Procedures Driving Market Growth

DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/8560e23d/cardiovascular_sur) has announced the addition of the "Cardiovascular Surgery Devices Market to 2017 - Technological Advances and Shift Towards Minimally Invasive Procedures Driving Market Growth" report to their offering.

GBI Research's report, Cardiovascular Surgery Devices Market to 2017 - Technological Advances and Shift towards Minimally Invasive Procedures Driving Market Growth provides key data, information and analysis of the global cardiovascular surgery devices market. The report provides information on the market landscape and competitive landscape, and market trend information for four cardiovascular surgery devices market categories: perfusion disposables, beating heart surgery systems, cardiopulmonary bypass (CPB) equipment and cardiac ablation devices.

The report provides comprehensive information on the key trends affecting these categories and key analytical content of market dynamics. The report also reviews the competitive landscape, major mergers and acquisitions in the last six years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The Global Cardiovascular Surgery Devices Market is Forecast to Reach $1.6 Billion in 2017

The global cardiovascular surgery devices market is forecast to reach $1.6 billion by 2017, with a compound annual growth rate (CAGR) of -1.3% from 2010-2017. The cardiovascular surgery devices market is expected to decline in this period due to the increasing adoption of alternative treatment procedures, such as percutaneous coronary intervention (PCI) and other minimally invasive interventions, and the shortage of cardiac surgeons in the US. In addition to this, a falling average selling price (ASP) and cost containment pressures in developed economies will also negatively affect the cardiovascular surgery devices market.

Companies Mentioned:

- Medtronic, Inc

- Sorin Group

- MAQUET GmbH & Co. KG

- Terumo Corporation

For more information visit http://www.researchandmarkets.com/research/8560e23d/cardiovascular_sur